NFKB1 and glioblastoma: Another peptide-based strategy is to target key cellular signaling pathways involved in GBM, for example, the constitutive activation of the NF-kβ pathway that has been shown to drive a mesenchymal pattern of differentiation associated with shorter survival and radio-resistance [57].